Needham analyst David Saxon reiterated a Buy rating on DENTSPLY SIRONA (XRAY – Research Report) today and set a price target of $25.00.Invest ...
CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor ...
Jefferies Financial Group downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) from a buy rating to a hold rating ...
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shares faced a downgrade in stock rating by Jefferies from Buy to Hold, with a significant reduction in the price target to $20.00 from the previous $30.00. The firm ...
Needham analyst David Saxon raised the firm’s price target on Dentsply Sirona (XRAY) to $25 from $23 and keeps a Buy rating on the shares ahead ...
The Bragar Eagel & Squire law firm is investigating claims against Dentsply Sirona on behalf of long-term stockholders. Six notes: 1. The law firm is looking into whether the dent ...
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DENTSPLY SIRONA Inc. ...
The Portnoy Law Firm advises Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) investors of a class action representing investors that bought securities between February 28, 2022, and ...